FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.
|Number of pages
|Japanese Journal of Clinical Radiology
|Published - Oct 1 2014
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging